Huyabio International, Llc.
Clinical trials sponsored by Huyabio International, Llc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug HBI-2376 targets Hard-to-Treat cancers in early trial Results expected Dec 2026 (estimated)
- New drug targets Hard-to-Treat cancers in early trial Results expected Dec 2026 (estimated)